Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells
Journal of Pharmacological Sciences · 2023
DOI: 10.1016/j.jphs.2023.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2023. Verfasst von Omer Faruk Hatipoglu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, Japan. Hauptthemen laut MEDLINE: Histamine, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kindai University, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Histamine is a well-known inflammatory mediator, but how histamine induces angiogenesis remains poorly understood. In the present study, we demonstrated a dose-dependent dynamic tube formation in the human endothelial cell line EA.hy926 in the presence of histamine that was completely blocked by histamine H1 receptor (H1R) and protein kinase C (PKC) inhibitors. However, histamine H2, H3, and H4 receptor inhibitors did not inhibit tube formation, suggesting that H1R-PKC signaling is involved in histamine-induced tube formation. Moreover, we found an H1-specific induction of vascular endothelial growth factor (VEGF) expression. Inhibition of VEGF receptor 2 (VEGFR2) suppressed the histamine-induced tube formation, indicating that VEGF is downstream of histamine signaling. Additionally, we demonstrated that histamine stimulation induces the expression of critical regulators of angiogenesis such as matrix metalloproteinase (MMP)-9 and MMP-14 metalloproteases, as histamine-induced tube formation is blocked by MMP inhibitors. In summary, our study indicates that histamine can activate the H1R in human endothelial cells and thereby promote tube formation through the PKC, MMP, and VEGF signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
- Department of Translational Research & Dug Development, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, Japan.
- Department of Pharmacology, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Naka-ku, Okayama, Japan.
- Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
- Department of Pharmacology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, Japan. Electronic address: wake-h.kindai@med.kindai.ac.jp.
Förderung
- Kindai University
- Japan Society for the Promotion of Science
Zitieren
APA
Hatipoglu, O. F., Nishinaka, T., Nishibori, M., Watanabe, M., Toyomura, T., Mori, S., Yaykasli, K. O., Wake, H., & Takahashi, H. (2023). Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2023.02.006
Vancouver
Hatipoglu OF, Nishinaka T, Nishibori M, Watanabe M, Toyomura T, Mori S, et al. Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. Journal of Pharmacological Sciences. 2023. doi:10.1016/j.jphs.2023.02.006
BibTeX
@article{Hatipoglu2023,
author = {Hatipoglu, Omer Faruk and Nishinaka, Takashi and Nishibori, Masahiro and Watanabe, Masahiro and Toyomura, Takao and Mori, Shuji and Yaykasli, Kursat Oguz and Wake, Hidenori and Takahashi, Hideo},
title = {Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells},
journal = {Journal of Pharmacological Sciences},
year = {2023},
doi = {10.1016/j.jphs.2023.02.006}
}
EUVIMED